Phase 1 Clinical Trials

More and more clients are adopting our innovative Translational Pharmaceutics approach, in order to accelerate their new drugs through early clinical development…

…..but did you know we are also one of the leading Phase 1 clinical pharmacology companies in the world?

  • 600+ employees and growing
  • 3 purpose built Phase I units, two in Florida (US) and one in Nottingham (UK) 
  • 420 bed capacity 
  • 15 full-time physicians with 10 Principal Investigators 
  • >1200 Phase I studies completed 
  • Average UK CTA approval time of 17 days 
  • Average US IRB approval time of 10 days
  • Database of >25,000 healthy volunteers 
  • GMP manufacturing of simple and complex dosage forms for all delivery routes 
  • Full service medical writing, data management, pharmacokinetics, statistical analysis & reporting 

All studies are conducted to the highest standards with meticulous attention to detail by our experienced clinical team.

Your Project Manager will guide the study to successful delivery on time and to budget.                            

Find out more about our clinical pharmacology programs and access our fact sheet here.

Get in touch and explore how we can help you design and implement the best clinical pharmacology program for your molecule.